Delivery Order SPE2DB20D1004-SPE2DB23FG5Q8
- Not listed
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order for the supply of 180 tablets of Mesalamine 800 mg delayed-release tablets. The contract, valued at $7,879.55, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency that provides medical supplies to military treatment facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Mesalamine DR 1.2 GM Tablet 120S. The $1,541.04 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of MESALAMINE DR 1.2 GM TABLET 120S. The $1,621.24 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,594.32 Firm Fixed Price delivery order is for the supply of 4566550847 MESALAMINE DR 1.2 GM TABLET 120S. The contract has an ultimate completion date of November 27, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the U.S. Department of Defense. The contract, valued at $1,261.92, is for the delivery of 120 tablets of Mesalamine DR 1.2 GM, a medication used to treat certain gastrointestinal conditions. The contract has an ultimate completion date of November 18, 2024. Amerisourcebergen holds a...
- This federal contract award is for the delivery of MESALAMINE 800 MG DR TABLET 180S to the Defense Logistics Agency (DLA). The $11,379.36 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on January 10, 2025. The contract has an ultimate completion date of January 13, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- This federal contract award, valued at $10,328.09, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for MESALAMINE DR 1.2 GM TABLET 120S, with a firm fixed price and an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,355.58 firm fixed-price delivery order is for the supply of 180 count bottles of 800 mg delayed-release mesalamine tablets, with a completion date of March 14, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $2,020.34 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the provision of MESALAMINE DR 1.2 GM TABLET 120S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $11,412.14 contract is for the delivery of 180 tablets of 800 mg mesalamine delayed-release medication. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB23FG5Q8Delivery Order
This federal contract award is for the delivery of 120 tablets of 1.2 gram mesalamine delayed-release tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,286.56, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price delivery order type and an ultimate completion date of September 15, 2023. This contract is not designated as a set-aside procurement. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/14/23 |